{"database": "lobbying", "table": "lobbying_activities", "rows": [[631747, "9aec6462-19f8-40b1-9eb5-cc1568a2bad5", "Q2", "PARRY, ROMANI, DECONCINI & SYMMS", 30792, "INTL ACADEMY OF COMPOUNDING PHARMACISTS", 2008, "second_quarter", "PHA", "Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens (see next page). Support of H. Con. Res. 342, Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. (Introduced in House), and\n\nSupport of S. Con. Res. 88, Support of Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest. (Introduced in Senate)", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2008-07-16T18:05:16-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["631747"], "units": {}, "query_ms": 0.3659109934233129, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}